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41 lesions, 22 lesions were followed without treatment. Angiographic character-
istics of septal channel perforation were Ellis class I (n14), class II (n2), and
class IIICS (n6). Septal channel perforation occurred in guidewire (n13),
balloon dilatation (n8), and microcatheter (n1). The angiographic follow up
rate was 81.8% (class I: n11, class II: n2, and class IIICS: n5). Persistent
septal channel perforation disappeared at follow up angiography in all lesions.
Conclusions: Persistent septal channel perforation into the ventricle and coronary sinus
or of non-spreading myocardial blush may have a good outcome.
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Background: The impact of successful chronic total occlusion (TO) recanalisation
and completeness of revascularisation after PCI on long-term survival remains
unsettled.
Methods: Within the All-Comers SYNTAX Trial (n2636), the PCI and CABG arms
were stratified by the presence of TOs and complete (CR) vs. incomplete (ICR)
revascularisation. Clinical outcomes (Kaplan-Meier) were analysed with log-rank and
Cox regression analyses.
Results: In the randomised population, recanalisation/bypass rates of 49.4% (PCI)
vs. 68.1% (CABG) were reported. In the All-Comers population, 840 patients
(PCI: 26.3%, CABG: 36.4%, p0.001) with 1007 TOs were identified. The
presence of TOs was significantly associated with less CR by PCI (CR: TO 34.3%,
non TO 59.8%, p0.001) and CABG (CR: TO 64.8%, non TO 69.8%, p0.048).
The presence of a TO was the strongest independent predictor of ICR after PCI
(Hazard Ratio [95% CI]: 2.85 [2.09, 3.87], p0.001). Regardless of the presence
of a TO in the PCI & CABG arms, CR (compared to ICR) was associated with
significant reductions in 4-year mortality, all-cause revascularisation, and
MACCE. Four-year stent thrombosis rates in the PCI arm were significantly lower
with CR (3.7%) vs. ICR (6.5%, p0.046), an effect that was more pronounced in
the TO group.
Conclusions: Within the PCI and CABG arms of the All-Comers SYNTAX Trial
– and specifically in all patients with TOs – whatever the acceptable threshold of
revascularisation is appropriate for an individual patient, the identification of ICR
(compared to CR) using the SYNTAX Trial definition identifies patients who have
an adverse longer-term prognosis.
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Background: Interventions on chronic total occlusions (CTO) demand expert operator
skills, longer procedural time and are more frequently associated with complications.
Current guidelines for percutaneous coronary interventions (PCI) for CTO are based on
small retrospective studies and expert consensus. Consequently, there is a necessity to
strengthen such a recommendation with more evidence. The aim of this study was to
report and describe prevalence, demographics, clinical characteristics, treatment decisions
and trends in reporting on CTO at the level of one whole nation using data from the
Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
Methods: SCAAR contains data on all consecutive patients who undergoes coronary
angiography or PCI in Sweden since 1989. Diagnosis of CTO in SCAAR is based on two
variables. The first variable is PCI physician’s mandatory evaluation of whether the
treated occluded segment is more than three months old. The second variable is a
non-mandatory reporting of lesions % stenosis in coronary artery segments.
Results: In January 2012, the SCAAR registry consisted of 497,572 procedures
performed in 348,863 patients. In total, 29,571 patients with a CTO were identified. A
CTO was observed in 10.9% of all performed procedures. In patients with significant
coronary lesions, a CTO was seen in 15.9%. CTO patients had more cardiovascular risk
factors and more extensive coronary artery disease. The majority of CTO patients were
treated conservatively and PCI revascularization of CTO is performed only in 5.8% of all
procedures. Revascularized CTO patients were younger and had more severe symptoms
while CTO patients with diabetes and multivessel disease were more likely to be referred
to CABG.
Conclusions: SCAAR is the largest data base of CTO patients to date. CTO is a frequent
finding in patients undergoing coronary angiography in Sweden and the number of CTO
procedures has been constant over the last 13 years. SCAAR may be a valuable source of
relevant clinical data in the process of building the real world evidence for the guidelines
regarding the optimal treatment of CTO patients.
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Background: Periprocedual myocardial infarction (PMI) in percutaneous coronary
intervention was reported to associate with increased risk of death in long-term follow-up.
However, there is a paucity of information about PMI in patients undergoing percutaneous
coronary intervention for chronic total occlusion (CTO-PCI). In this study, we investi-
gated incidence, predictors of PMI and prognostic impact after CTO-PCI.
Methods: We reviewed our CTO-PCI database and examined the incidence of PMI in
patients who had attempted CTO recanalization between 2003 and 2009. PMI was defined as
an increase of CK or CK-MB level more than three times higher than normal limit in
measurement within 24 hours after index procedure. All cause mortality was estimated at 5
years (median: 2.5 years; interquartile range: 1.8 to 3.5 years) according to Kaplan-Meier
analysis.
Results: Nine hundred and forty-five patients underwent CTO-PCI (mean age 63	/ 10
years old; 89% male) were enrolled. Overall procedure success rate was 70%. PMI was
observed in 53 (5.6%) of all patients and occurred more in failed patients than in
successful patients (7.1% vs 5.0%, p0.2). PMI patients had significantly less prior
history of myocardial infarction and of PCI and less hypercholesterolemia. CTO lesions
related to PMI were located less frequently in-stent and more in the contest of multivessel
disease compared to lesions without PMI. At 5 years follow-up, patients with PMI showed
significant higher rate of mortality compared to that without (29% vs 9 %, p0.0006). At
multivariate analysis, PMI (HR: 2.95, 95%CI: 1.27 to 6.02, p0.014), age (HR: 1.09,
95%CI: 1.06 to 1.12, p0.0001), chronic kidney disease (HR: 4.47, 95%CI: 2.38 to 8.10,
p0.0001) and left ventricular ejection fraction (HR 0.94, 95%CI: 0.92 to 0.96,
p0.0001) were significant predictors of all cause mortality.
Conclusions: In our registry, PMI was observed in 5.6% of CTO-PCI. PMI was an
independent predictor of all cause mortality in long-term follow up. From these data, we
don’t determine if PMI is a marker of more advanced disease or a true causative factor.
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